stay updated with our newsletter

Could the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?

THC or CBD Content

The disabling condition of obsessive-compulsive disorder (OCD) affects about 2–3% of people worldwide. Evidence suggests that abnormalities in cortico-striatal-thalamic-cortical circuitry and specific gene variants contribute to the pathogenesis of the disorder. This latest study, published in Cannabis and Cannabinoid Research, suggests that the endocannabinoid system (ECS) plays a role in OCD symptomsRead

Researchers Say Soy-Foods Health Claim Should Remain Based on Credible Science

soy protein

The FDA is currently reviewing a proposal to revoke the cardiovascular health claim for soy foods. Is the revocation warranted? Researchers at the University of Toronto say no. The research, published in the Journal of the American Heart Association, have found a consistent cholesterol-lowering effect for soy foods protein, withRead

JOIN OUR MAILING LIST

Weekly round-up, access to thought leaders, and articles to help you improve health outcomes and the success of your practice.